Sodium‐glucose cotransporter 2 inhibitor luseogliflozin improves glycaemic control, assessed by continuous glucose monitoring, even on a low‐carbohydrate diet

This randomized, double‐blind, placebo‐controlled, crossover study was the first to determine the effects of luseogliflozin in combination with a low‐carbohydrate diet (LCD) on 24‐h glucose variability, assessed by continuous glucose monitoring (CGM). A total of 18 Japanese patients with type 2 diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, R., Omiya, H., Sugio, K., Ubukata, M., Sakai, S., Samukawa, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2016
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066655/
https://www.ncbi.nlm.nih.gov/pubmed/26639943
http://dx.doi.org/10.1111/dom.12611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066655/
https://www.ncbi.nlm.nih.gov/pubmed/26639943
http://dx.doi.org/10.1111/dom.12611

Ejemplares similares